News - Mitorx

- Event
BIO-Europe, November 9-11
Read More
- Event
Sachs 2nd Annual Obesity and Cardiometabolic Innovation Forum, June 5
Read More
- Event
American Diabetes Association Scientific Sessions 2026, June 5-8
Read More
- Publication
- Posted 1 June, 2026
Myo-004 (MTRX31) induces bodyweight loss in DIO at thermoneutrality by switching metabolism from fat to carbohydrate oxidation
Read More
- Event
European Association for the Study of Diabetes (EASD), 28 September – 2 October
Read More
- Press Release
- Posted 17 November, 2025
MitoRx Therapeutics raises GBP 5.5 million pre-series A round to advance a next generation obesity treatment
Read More
- Press Release
- Posted 16 September, 2025
MitoRx Therapeutics presents additional muscle preservation and liver-fat clearance data in obesity at EASD
Read More
- In The Media
- Posted 29 August, 2025
Rethinking Weight Loss Treatments – The Medicine Maker
Read More
- Publication
- Posted 26 August, 2025
Characterization of Myo4 in the murine diet-induced obesity model: a first-in-class anti-obesogenic muscle-preserving small molecule metabolic modulator
Read More
- In The Media
- Posted 7 July, 2025
New data backs Myo4 for obesity treatment – Drug Target Review
Read More